Signature Global to invest ₹2,200 cr on new housing project in Gurugram
New Delhi, Jun 29 (PTI) Realty firm Signature Global will invest around ₹ 2,200 crore to develop a new housing project in Gurugram to expand business and achieve over 20 per cent growth in its pre-sales this fiscal year. Signature Global said on June 30 that it has sold premium flats worth more than ₹ 2700 crore in its new project in Gurugram on the back of strong housing demand (Representational Image)(File Photo )
The company has recently launched a premium residential project, 'Cloverdale', comprising 770 apartments, on Southern Peripheral Road (SPR), Sector 71, Gurugram.
Signature Global emerged as the fifth largest listed real estate developer last fiscal in terms of sales bookings by achieving record pre-sales of ₹ 10,290 crore.
The Gurugram-based company has given a guidance of posting ₹ 12,500 crore worth pre-sales in the current fiscal.
"We have launched a new housing project in Gurugram. Housing demand continues to be strong in this city, especially for reputed builders," Signature Global Chairman Pradeep Kumar Aggarwal told PTI.
The company is selling homes in a price range of ₹ 4 crore to ₹ 7 crore in this project, which is spread over 8 acres and is part of an overall 22-acre development.
Also Read: Signature Global to invest ₹ 4,000 crore on two new projects in Gurugram
The project is scheduled to be completed by 2031.
Last month, Aggarwal said the company will invest around ₹ 4,000 crore this fiscal to acquire land parcels and carry out construction activities in its housing projects at Gurugram.
Signature Global had invested ₹ 1,070 crore last fiscal year to purchase 48 acres of land in Gurugram, Haryana.
"Land is an important raw material for real estate developers. We will be investing around ₹ 1,200-1,500 crore on the acquisition of land parcels," he had said.
Aggarwal said the investment in construction activities would be around ₹ 2,500 crore in 2025-26 against ₹ 1,900 crore in the preceding fiscal.
Last week, Signature Global announced plans to raise ₹ 875 crore through issue of non-convertible debentures to refinance debt and expand business.
"We have taken the approval of board to raise funds. We will also seek shareholders approvals," Aggarwal said.
He said the company will use ₹ 450 crore to refinance its existing debt while the remaining amount will be for business growth.
Aggarwal said the company is targeting to raise funds by end of August, subject to shareholders' approval.
Also Read: Signature Global acquires over 8 acres of land in Gurugram for ₹ 282 crore
Signature Global, one of the leading real estate developers in the country, started its business to develop affordable housing projects but shifted its focusing on mid-income, premium and luxury segments because of high land cost in Gurugram.
It posted a net profit of ₹ 101.2 crore last fiscal, a sharp jump from ₹ 16.32 crore in the preceding year.
Its total income grew to ₹ 2,637.99 crore in the last fiscal from ₹ 1,324.55 crore in 2023-24.
Since inception, Signature Global has delivered 13.5 million square feet of housing projects and has a strong pipeline of about 21.6 million sq ft of saleable area in upcoming projects, along with 46.38 million sq ft of ongoing projects, targeted for completion within the next 2-3 years.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
&w=3840&q=100)
Business Standard
26 minutes ago
- Business Standard
Torrent Pharma to acquire JB Pharma from KKR at ₹25,689 cr valuation
In one of the largest pharma deals in the domestic market in recent years, Ahmedabad-based Torrent Pharmaceuticals will acquire a controlling stake in investment firm KKR-backed JB Chemicals and Pharmaceuticals (known as JB Pharma) at an equity valuation of ₹25,689 crore, which will be followed by the merger of the two entities. The deal will be executed in two phases — acquisition of the 46.39 per cent stake held by KKR in JB Pharma at ₹1,600 per share, amounting to ₹11,917 crore, followed by a mandatory open offer to acquire up to 26 per cent of JB Pharma shares from public shareholders at ₹1,639.18 per share. 'In addition to the above, Torrent has also expressed its intent to acquire up to 2.8 per cent of equity shares from certain employees of JB Pharma at the same price per share as KKR,' the company said in a statement on Sunday. The next step in the deal will be a merger between Torrent Pharma and JB Pharma through a scheme of arrangement, under which every shareholder holding 100 shares in JB Pharma will receive 51 shares of Torrent Pharma. The boards of directors of both companies have approved this arrangement. KKR had acquired 54 per cent of JB Pharma in July 2020 from the promoters and founders, the Mody family, for approximately ₹3,100 crore (or ₹745 per share). It sold a part of its stake in March this year through block deals for ₹1,459.8 crore. KKR has earned more than five times on its investment, with around 36 per cent gross IRR. For instance, Torrent Pharma has previously indicated plans to increase its medical representative (MR) strength by 23 per cent by the end of FY26, and the acquisition can aid in manpower augmentation. Torrent Pharma holds a 3.74 per cent share in the domestic market (according to Pharmarack, May 2025), while JB Pharma commands a 1.12 per cent share. Further, consolidation in key international markets is expected to offer greater scalability. Samir Mehta, executive chairman of Torrent Pharma, said they want to build on JB Pharma's heritage and platform for the future. 'Torrent's deep India presence and JB Pharma's fast-growing India business, combined with the CDMO and international footprint, offer immense potential to scale both revenue and profitability. This strategic alignment furthers our goal of strengthening our presence in the Indian pharma market and builds a larger diversified global presence. Moreover, the CDMO platform provides a new long-term avenue of growth for Torrent.' Torrent has previously taken the inorganic route to grow its business and enter newer segments — in 2013, it acquired Elder Pharma's India-branded business; followed by the dermaceutical business of Zyg Pharma in 2015 and the API plant of Glochem Industries in 2016. Among other major deals, it bought the India-branded business of Unichem in 2017. Its last major acquisition was of skin-care products from Curatio Healthcare in 2022. Torrent Pharma is a highly domestic-focused company, drawing around 55 per cent of its consolidated revenues from the domestic formulations business. India sales grew by 13 per cent in FY25 to ₹6,393 crore. While the company has been outperforming industry growth in the domestic market, it is also planning to increase MR strength by 23 per cent by FY26-end. Torrent has a strong presence in the cardiovascular, gastrointestinal and neurology segments. JB too has prominent cardiac and gastro brands like Cilacar, Metrogyl and Rantac. Torrent is also working on launching GLP-1 products as a day-one launch in FY26. Analysts expect a 15 per cent sales CAGR in domestic formulations for Torrent Pharma over FY25–27. Gaurav Trehan, co-head of Asia Pacific and head of Asia Pacific private equity at KKR, and CEO of KKR India, said: 'JB Pharma's transformation under our stewardship is a testament to KKR's ability to scale high-quality companies.' Nikhil Chopra, chief executive officer and whole-time director of JB Pharma, pointed out that over the past five years, the company has emerged as one of India's fastest-growing pharmaceutical players. 'We have built a strong foundation to deliver market-leading growth, as well as consistent improvement in profitability in the medium and long term. As we now enter a new chapter alongside Torrent Pharmaceuticals, we are confident that the combined strengths of our organisations will unlock greater opportunities to enhance healthcare access across our markets,' Chopra said. JB Pharma posted 12 per cent revenue growth in FY25 to ₹3,918 crore, while its EBITDA rose 16 per cent to ₹1,087 crore, and PAT increased 19 per cent to ₹660 crore. Notably, KKR Private equity has invested $2 billion in India in 2024 and recently invested $600 million in Manipal Group via its private credit arm.
Hindustan Times
27 minutes ago
- Hindustan Times
From July 1, reservation charts to be released 8 hours before train departure
New Delhi: The Indian Railways on Sunday said that it would prepare the reservation chart eight hours before the train departure time, starting from July 1. The railways also said that it will introduce a Modern Passenger Reservation System (PRS) by December this year. (Representational image) As of now, the chart that determines whether waitlisted tickets are confirmed is prepared and released just four hours prior to the train's departure time. The move is expected to give passengers more clarity and time to make alternative travel arrangements in case their train tickets do not get confirmed. '..Wherever passengers are coming from a nearby area to catch the train, this uncertainty can cause serious problems. To remove this uncertainty, the railway board has proposed preparing the reservation chart eight hours before the departure,' a statement from the railways said. 'The Railway Minister agreed with this proposal and directed the board to start implementing this in phases so that there is no disruption,' it added. 'The passengers will get the first update on waitlist status well in advance. It will benefit passengers travelling from remote locations or suburbs of major cities for catching long distance trains. It will also provide more time to make alternative arrangements in case the wait list is not confirmed,' the railways said, adding that it will reduce uncertainties for passengers with waitlist tickets. The railways also said that it will introduce a Modern Passenger Reservation System (PRS) by December this year. Railway minister Ashwani Vaishnaw reviewed the upgradation of the passenger reservation system, it said, adding that the project is being executed for the last few months by the Centre For Railway Information Systems (CRIS). 'The new upgraded PRS design to handle ten times the current load. It will significantly enhance the ticket booking capacity…it will allow over 1.5 lakh ticket bookings per minute. This will be an increase of roughly five times from 32,000 tickets per minute in the current PRS,' it said. 'The ticket enquiry capacity will jump ten times from 4 lakh to over 40 lakh per enquiry will be possible in a minute time. The new PRS also has a multilingual and user-friendly booking and enquiry interface,' the statement added. Passengers will be able to submit their choice of seat and see the fare calendar. It also has integrated facilities for Divyangjan, students, patients, it said. This comes after the railways announced that only authenticated users will be allowed to book Tatkal tickets on IRCTC website and mobile app beginning July 1 and that an OTP-based authentication will be done for Tatkal bookings from the end of July. 'The authentication will be done using Aadhaar or any other verifiable Government ID available in the user's DigiLocker account,' the statement concluded.
India.com
an hour ago
- India.com
Anil Ambani takes massive leap, takes part in global bids for...., Kuwait, UAE, and Malaysia will now be...
Anil Ambani (File) Anil Ambani takes massive leap: In a significant development for Mukesh Ambani's brother, Anil Ambani, Anil Ambani's Reliance Power Ltd is reportedly planning to set up a 1,500-MW gas-based power project overseas. Reliance Power is actively participating in several international tenders for its development and as per media report, Reliance Power has submitted competitive bids for gas-based power projects in Kuwait, UAE, and Malaysia as part of its selective global expansion strategy. Here are all the details you need to know about Anil Ambani's Reliance Power Ltd. What is Reliance Power planning? As per a report by PTI news agency, Anil Ambani's company has recently secured two mega power projects in Bhutan – a 500-MW solar project and a 770-MW hydropower project. As a part of the project, Reliance Power plans to relocate two 750 MW modules of world-class equipment currently in its possession in India. The PTI report also says that through the proposed project, the company aims to realise up to Rs 2,000 crore through the monetisation of these assets. Where are the Global projects of Reliance Power? The report mentions that the demand for gas-based power – widely regarded as a clean energy source – is significantly high in countries such as Kuwait, the UAE, and Malaysia. However, global suppliers like GE typically require 3 to 5 years to deliver equipment for gas or LNG-based power plants and in comparison, Anil Ambani's Reliance Power has 1,500 MW of equipment readily available, which helps it to execute such projects in the shortest possible timeframe, giving it a major edge over other global giants. How Reliance Power is focusing on renewable and clean energy! It should be noted that Reliance Power is actively focusing on renewable and clean energy. The company has a strong development pipeline, including 2.5 GWp of utility-scale solar projects and more than 2.5 GWh of Battery Energy Storage Systems (BESS). (With inputs from agencies)
